New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
An assessment of the role of vinculin (VCL) loss of function variants in inherited cardiomyopathy.
An assessment of the role of vinculin (VCL) loss of function variants in inherited cardiomyopathy. Human mutation Hawley, M. H., Almontashiri, N., Biesecker, L. G., Berger, N., Chung, W. K., Garcia, J., Grebe, T. A., Kelly, M. A., Lebo, M. S., Macaya, D., Mei, H., Platt, J., Richard, G., Ryan, A., Thomson, K. L., Vatta, M., Walsh, R., Ware, J. S., Wheeler, M., Zouk, H., Mason-Suares, H., Funke, B. 2020Abstract
The ACMG/AMP variant classification framework was intended for highly penetrant Mendelian conditions. While it is appreciated that clinically relevant variants exhibit a wide spectrum of penetrance, accurately assessing and expressing the pathogenicity of variants with lower penetrance can be challenging. The vinculin gene (VCL) illustrates these challenges. Model organism data provides evidence that loss of function of VCL may play a role in cardiomyopathy and aggregate case-control studies suggest low penetrance. VCL loss of function variants, however, are rarely identified in affected probands and therefore there is a paucity of family studies clarifying the clinical significance of individual variants. This study, which aggregated data from >18,000 individuals who underwent gene panel or exome testing for inherited cardiomyopathies, identified 32 probands with VCL loss-of-function variants and confirmed enrichment in probands with dilated cardiomyopathy (OR= 9.01; CI=4.93-16.45). Our data revealed that the majority of these individuals (89.5%) had pediatric onset of disease. Family studies demonstrated that heterozygous loss of function of VCL alone is insufficient to cause cardiomyopathy but that these variants do contribute to disease risk. In conclusion, VCL loss-of-function variants should be reported in a diagnostic setting but need to be clearly distinguished as having lower penetrance. This article is protected by copyright. All rights reserved.
View details for DOI 10.1002/humu.24061
View details for PubMedID 32516855